2024-12-28 04:29:54
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
Corporate/ 2023-07-23
Innovent Announces First Patient Dosed i...

SUZHOU,China,Aug. 3,2020-- Innovent Biologics,Inc. ("Innovent" or "the Company") (HKEX: 01801),a world-class biopharmace...

TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
Health/ 2023-07-22
TB Alliance Announces European Commissio...

Pretomanid,developed by the non-profit TB Alliance,has received EU marketing authorisation in combination regimen with bedaquiline and linez...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release